Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Ayre, C. Anthonissen, C. Martin, F. Turk, K. Thomas (Horsham, United Kingdom; Basel, Switzerland). Assessment of a responder identification treatment algorithm for omalizumab in a naturalistic setting. Eur Respir J 2007; 30: Suppl. 51, 3654

Member's Comments

No comment yet.

Related content which might interest you: Physician assessment of asthma control in patients receiving omalizumab in a real-world setting Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Adherence to omalizumab: a “real-life” study Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Development of a tool to measure the clinical response to biologic therapy in uncontrolled severe asthma: the FEOS score. Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 The effectiveness of different clinical measures in evaluating response to omalizumab Source: Annual Congress 2010 - Questionnaires use and psychological aspects in asthma Year: 2010 Asthma control with inhaled corticosteroid therapy: A real-world observational study Source: Annual Congress 2010 - Management of airway disease Year: 2010 Analysis of two-year treatment with omalizumab patients with severe asthma in real clinical practice Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Biomarker measurement in asthma patients receiving biologic therapy: a real-world retrospective study Source: International Congress 2018 – Eosinophils in airway disease Year: 2018 Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Clustering analysis for omalizumab responder patient profiles identification. Fenoma study Source: International Congress 2018 – Asthma management Year: 2018 Use of a protocol to select patients for omalizumab treatment Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008 Characteristics of patients receiving mepolizumab in real-world practice –REALITI-A study Source: International Congress 2018 – New developments in the treatment of asthma Year: 2018 Clinical and economic outcomes following 52-week add-on omalizumab Source: Annual Congress 2013 –Asthma drugs: new findings Year: 2013 Treatment and recovery of symptom-based exacerbations in the INSPIRE study Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008 Randomised control trial to investigate whether electronic adherence monitoring with reminder alarms and feedback can improve clinical outcomes in childhood asthma Source: International Congress 2015 – Paediatric asthma and allergy: e-health in management Year: 2015 Budesonide/formoterol maintenance and reliever therapy for asthma compared to conventional best practice: a randomised real-life study Source: Eur Respir J 2006; 28: Suppl. 50, 613s Year: 2006 Clinical phenotypes of asthmatics who require long-term use of tiotropium for asthma control: a real-world study Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019 Development and validation of a simple tool for clinical assessment of patients treated with home NIV: The S3-NIV questionnaire Source: International Congress 2017 – New insights in chronic respiratory failure Year: 2017 Treatment patterns in English asthma patients initiating multiple inhaler triple therapy: a cohort study Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights Year: 2020 Comparative efficacy of the therapy strategies for the asthma control maintenance in real clinical practice Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011 Evaluating response to omalizumab (anti-IgE) in clinical practice Source: Eur Respir J 2005; 26: Suppl. 49, 48s Year: 2005